Production Manager in Oxford

Company description:

OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

OXB collaborates with some of the world\’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB\’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Job description:

Production Manager

Join Us in Changing Lives

At?OXB, our people are at the heart of everything we do.Wereon a mission to enable life-changing therapies to reach patients around the worldandwerelooking for passionate individuals who embody our core values every day:?Responsible, Responsive, Resilient, and Respectful.

Were currently recruiting for a Production Manager to join our Manufacturing team. In this role, you will?coordinate the safe day to day operations and administrations of a manufacturing area to meet quality, customer demand and cost targets and to deputise for the Head of Manufacturing as required, playing a key part in advancing our mission and making a real difference.

Your responsibilities in this role would be:

• Taking accountability for the successful operation of designated manufacturing areas, including adherence to schedule and quality output.
• Ensuring designated areas compliance with Quality, Safety and Environmental systems and procedures.
• Creating a positive team dynamic and enable team strong performance and development.
• Implementing agreed manufacturing Key Performance Indicators.
• Developing external client relationships within Pharma/Biotech industry.
• Co-ordinating projects and customer needs for manufacturing.
• Deputising for the Head of Manufacturing during absences.
• Taking accountability for bringing together all support functions in order to keep the area moving forward.
• Perform as the Subject Matter Expert for GMP audits.

We are looking for:

• Degree in a science related subject and/or experience of working to GMP standard.
• Strong knowledge of GMP manufacturing and pharmaceutical quality systems.
• Competent at using data to drive decision making and evaluating safety and quality risk.
• Previous facility and people management experience.

About Us:

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturingexpertisein lentivirus, adeno-associated virus (AAV)and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatoryexpertise.

Why Join Us?

• ???Competitive total reward packages
• ???Wellbeing programmes?that support your mental and physical health
• ???Career development opportunities?to help you grow and thrive
• ???Supportive, inclusive, and collaborative culture
• ???State-of-the-art labs and manufacturing facilities
• ??A company that lives its values:?Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.

Ready to Make a Difference?

Collaborate. Contribute. Change lives.

Profile description:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world\’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica\’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world\’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica\’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.